About Us

Niskus is an established and reputable bio technology firm based in Ireland. Setup by Vincent Farrelly in 2022, we were rapidly identified as a promising start up company and we quickly received investment and recognition from multiple investment programmes and partners.

 

We are incredibly proud and grateful to have been supported by the following organisations:

 

Enterprise Ireland Pre-Seed Start Fund (PSSF) – Enterprise Ireland is the national business support agency. Their PSSF investment programme is geared towards early startups deemed to have very high potential.

 

Enterprise Ireland High Performing Startups (HPSU) – Enterprise Ireland’s HPSU funding supports High Potential Start-Ups (HPSUs). These businesses are internationally focused, have developed a minimal viable product (MVP) and have demonstrated some commercial traction.

 

Big Ideas Ventures New Protein Fund – Niskus is a portfolio member of The New Protein Fund I (size USD$50M) has invested in more than 100 of the most innovative companies focused on plant-based, cultivated and fermentation-enabled proteins, ingredients and technologies both directly and through its accelerator programs. NPF I is backed by leading food corporations including AAK, Avril, Bel, Bühler, Givaudan, Meiji, Temasek Holdings, and Tyson Ventures. Click here for more information and an overview of the global fund’s portfolio.

 

EIT Food – EIT Food is the world’s largest food community. Supported by the EU, EIT Food invest in projects, organisations and individuals that share our goals for a healthy and sustainable food system. Chosen innovation projects are delivered with a combination of industry, education and research partners to improve environmental and health outcomes.

​

Tech Tour Europe - Tech Tour is a merit-based ecosystem of select entrepreneurs, active investors and strategic partners collaborating to facilitate investment, scale companies, and transform bold innovations into global solutions. Niskus make the Top 200 round for Europe.